Skip to content

Opus Genetics IRD Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Operating margin-359.1%+112pp-271.9%+293pp-445.4%-93.7pp-420.7%-329pp-471%-407pp
Net margin-892.4%-463pp-349.3%+174pp-466.1%-142pp-377.9%-292pp-429.4%-370pp
Efficiency
Asset turnover0.2×-0.1×0.3×+0.1×0.4×+0.2×0.4×0.0×0.3×-0.1×
Liquidity
Current ratio7.1×+5.2×6.4×+3.2×1.2×-5.4×1.9×-8.8×-7.0×
Per Share
Book value per share-$0.53-452%$0.25-2.0%$0.08-93.6%$0.28-82.5%$0.15-92.0%
Valuation
Market capitalization$307.14M+442%$138.62M+269%$98.85M$55.1M$44.15M
Price / sales25.6×+21.5×9.8×+6.3×6.8×3.6×3.2×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Opus Genetics's ratios come from?
Every ratio is computed from Opus Genetics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.